Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Diversified Trust Co

Posted by Defense World Staff on Mar 26th, 2023

Diversified Trust Co raised its position in Agilent Technologies, Inc. (NYSE:A – Get Rating) by 34.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 5,876 shares of the medical research company’s stock after buying an additional 1,493 shares during the quarter. Diversified Trust Co’s holdings in Agilent Technologies were worth $879,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of A. EverSource Wealth Advisors LLC raised its stake in shares of Agilent Technologies by 34.8% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock worth $37,000 after buying an additional 77 shares in the last quarter. King Luther Capital Management Corp lifted its holdings in Agilent Technologies by 0.3% in the third quarter. King Luther Capital Management Corp now owns 24,625 shares of the medical research company’s stock valued at $2,993,000 after acquiring an additional 78 shares during the period. Bell Investment Advisors Inc boosted its position in shares of Agilent Technologies by 2.1% during the 3rd quarter. Bell Investment Advisors Inc now owns 4,153 shares of the medical research company’s stock worth $505,000 after purchasing an additional 86 shares in the last quarter. Mutual Advisors LLC boosted its position in shares of Agilent Technologies by 1.4% during the 3rd quarter. Mutual Advisors LLC now owns 6,638 shares of the medical research company’s stock worth $807,000 after purchasing an additional 89 shares in the last quarter. Finally, Spinnaker Trust grew its stake in shares of Agilent Technologies by 3.1% during the 3rd quarter. Spinnaker Trust now owns 3,139 shares of the medical research company’s stock worth $382,000 after purchasing an additional 95 shares during the period.

Agilent Technologies Trading Up 0.6 %

Agilent Technologies stock opened at $131.96 on Friday. The stock has a market cap of $39.02 billion, a PE ratio of 29.79, a P/E/G ratio of 1.96 and a beta of 1.04. The company has a current ratio of 2.11, a quick ratio of 1.53 and a debt-to-equity ratio of 0.49. The stock has a 50-day moving average price of $146.42 and a 200 day moving average price of $143.11. Agilent Technologies, Inc. has a 52 week low of $112.52 and a 52 week high of $160.26.

Agilent Technologies (NYSE:A – Get Rating) last issued its quarterly earnings results on Tuesday, February 28th. The medical research company reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.70 billion. Agilent Technologies had a net margin of 19.09% and a return on equity of 30.35%. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.21 earnings per share. Equities research analysts predict that Agilent Technologies, Inc. will post 5.68 earnings per share for the current fiscal year.

Agilent Technologies announced that its board has approved a stock repurchase plan on Monday, January 9th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical research company to reacquire up to 4.4% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 26th. Stockholders of record on Tuesday, April 4th will be issued a dividend of $0.225 per share. This represents a $0.90 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Monday, April 3rd. Agilent Technologies’s dividend payout ratio (DPR) is 20.32%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. SVB Leerink boosted their price objective on shares of Agilent Technologies from $160.00 to $170.00 and gave the stock an “outperform” rating in a report on Friday, January 6th. UBS Group upped their price target on Agilent Technologies from $152.00 to $170.00 and gave the stock a “buy” rating in a report on Tuesday, December 20th. StockNews.com initiated coverage on Agilent Technologies in a report on Thursday, March 16th. They set a “strong-buy” rating for the company. Robert W. Baird boosted their target price on Agilent Technologies from $170.00 to $174.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 1st. Finally, Credit Suisse Group raised their price target on Agilent Technologies from $165.00 to $170.00 and gave the company an “outperform” rating in a research report on Wednesday, March 1st. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $163.31.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.